114
Views
9
CrossRef citations to date
0
Altmetric
Original

Effect of Telmisartan and Amlodipine on Home Blood Pressure by Monitoring Newly Developed Telemedicine System: Monitoring Test by Using Telemedicine. Telmisartan's Effect on Home Blood Pressure (TelTelbosu)

, , , , , & show all
Pages 57-67 | Received 31 Aug 2005, Accepted 22 Feb 2007, Published online: 03 Jul 2009

References

  • Formica M, Quarello F, Stramignoni E, et al. Informatics support and teledialysis. Minerva Urol Nefrol. 1994; 46: 11–16, (in Italian).
  • Nakamoto H, Kawamoto A, Tanabe Y, Nakagawa Y, Nishida E, Akiba T, Suzuki H. Telemedicine system for CAPD patients by using cellular phone. Adv. Perit. Dial. 2006; 19: 124–129
  • Nakamoto H, Hatta M, Tanaka A, Moriwaki K, Oohama K, Kagawa K, Wada K, Suzuki H. Telemedicine system for home automated peritoneal dialysis. Adv. Perit. Dial. 2000; 16: 191–194
  • Assaad MAE, Topouchian JA, Asmar RG. Evaluation of two devices for self-measurement of blood reassure according to the international protocol: The Omron M5-I and the Omron 705IT. Blood Pressure Monitoring. 2003; 8: 127–133
  • Imai Y, Otsuka K, Kawano Y, Shimada K, Hayashi H, Tochikubo O, Miyakawa M, Fukiyama K. Japanese Society of Hypertension (JSH) guidelines for self-monitoring of blood pressure at home. Hypertens Res. 2003; 26: 771–782, and the Japanese Society of Hypertension
  • Imai Y, Hozawa A, Ohkubo T, Tsuji I, Yamaguchi J, Matsubara M, Michimata M, Hashimoto J, Fujiwara T, Nagai K, Kitaoka H, Satoh H, Hisamichi S. Predictive values of automated blood pressure measurement: What can we learn from the Japanese population—the Ohasama study. Blood Press Monit. 2001; 6: 335–339
  • Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, Menard J, Mallion JM. Cardiovascular prognosis of “masked hypertension” detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004; 291: 1342–1349
  • Chobanian AV, Bakris GL, Black PR, Cushman WC, Green LA, Izzo JL, Jr, Jones DW, Materson BJ, Oparil S, Wright JT, Jr, Roccella EJ, the National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA. 2003; 289: 2560–2572
  • Whitworth JA, the World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003; 21: 1983–1992
  • European Society of Hypertension—European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension—European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003; 21: 1011–1053
  • Saruta T. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2004). Nippon Rinsho. 2005; 63: 952–958, (in Japanese).
  • Haynes RB, Sackett DL, Gibson ES, Taylor DW, Hackett BC, Roberts RS, Johnson AL. Improvement of medication compliance in uncontrolled hypertension. Lancet. 1976; 1(7972)1265–1268
  • O'Brien E, Mee F, Fitzgerald D. The history of blood pressure measurement. J Hum Hypertens. 1994; 8: 73–84
  • O'Brien E, Beevers G, Lip GHY. ABC of hypertension, part IV: Automated sphygmomanometry: Self blood pressure measurement. BMJ 2001; 322: 1167–1170
  • Imai Y, Poncelet P, DeBuyzere M, Padfield PL, Van Montfrans GA. Prognostic significance of self-measurements of blood pressure. Blood Press Monit. 2000; 5: 137–143
  • Imai Y, Nishiyama A, Ohkubo T, Tsuji I, Nagai K, Kikuchi N, Satoh H, Hisamichi S. Factors affecting the nocturnal decrease in blood pressure: A community-based study in Ohasama. J Hypertens. 1997; 15: 827–838
  • Suzuki H, Nakamoto H, Okada H, Sugahara S, Kanno Y. Self-measured systolic blood pressure in the morning is a strong indicator of decline of renal function in hypertensive patients with non-diabetic chronic renal insufficiency. Clin Exp Hypertens. 2002; 24: 249–260
  • Suzuki H, Kanno Y, Ikeda Y, Nakamoto H, Okada H, Sugahara S. Selection of the dose of angiotensin converting enzyme inhibitor for patients with diabetic nephropathy depends on the presence or absence of left ventricular hypertrophy. Hypertens Res. 2002; 25: 865–873

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.